Yoshie ARAI,Margaret Elizabeth Brosseau,Jessie Gu,Tomoko Hayashi,Hironobu Mitani,Muneto Mogi,Kazuhiko Nonomura,Ken Yamada
申请号：
US15831545
公开号：
US20180153861A1
申请日:
2017.12.05
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides a compound of Formula I for use in the treatment, amelioration and/or prevention of diseases and conditions associated with CETP activity, such as atherosclerosis and dyslipidemia, in a subject with high triglyceride level wherein R1, X1, R7, R5, C, L and p are defined herein. The present invention further provides a combination of pharmacologically active agents for use in the treatment, amelioration and/or prevention of diseases and conditions associated with CETP activity, such as atherosclerosis and dyslipidemia, in a subject with high triglyceride levels.
